|
1
|
Nashimoto M: Specific cleavage of target
RNAs from HIV-1 with 5′ half tRNA by mammalian tRNA 3′ processing
endoribo-nuclease. RNA. 2:523–524. 1996.PubMed/NCBI
|
|
2
|
Tamura M, Nashimoto C, Miyake N, Daikuhara
Y, Ochi K and Nashimoto M: Intracellular mRNA cleavage by 3′ tRNase
under the direction of 2′-O-methyl RNA heptamers. Nucleic Acids
Res. 31:4354–4360. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nashimoto M: Anomalous RNA substrates for
mammalian tRNA 3′ processing endoribonuclease. FEBS Lett.
472:179–186. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takaku H, Minagawa A, Takagi M and
Nashimoto M: A novel 4-base-recognizing RNA cutter that can remove
the single 3′ terminal nucleotides from RNA molecules. Nucleic
Acids Res. 32:e912004. View Article : Google Scholar
|
|
5
|
Shibata HS, Takaku H, Takagi M and
Nashimoto M: The T loop structure is dispensable for substrate
recognition by tRNase ZL. J Biol Chem. 280:22326–22334. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Elbarbary R, Takaku H, Tamura M and
Nashimoto M: Inhibition of vascular endothelial growth factor
expression by TRUE gene silencing. Biochem Biophys Res Commun.
379:924–927. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nakashima A, Takaku H, Shibata HS, Negishi
Y, Takagi M, Tamura M and Nashimoto M: Gene silencing by the tRNA
maturase tRNase Z(L) under the direction of small-guide RNA. Gene
Ther. 14:78–85. 2007. View Article : Google Scholar
|
|
8
|
Sano T, Takahashi M, Nozaki T, Takahashi
Y, Tamura M and Nashimoto M: Expanding the utility of heptamer-type
sgRNA for TRUE gene silencing. Biochem Biophys Res Commun.
416:427–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Takahashi M, Elbarbary RA, Nakashima A,
Abe M, Watanabe N, Narita M, Takahashi M, Tamura M, Yoshida T and
Nashimoto M: A naked RNA heptamer targeting the human Bcl-2 mRNA
induces apoptosis of HL60 leukemia cells. Cancer Letters.
328:362–368. 2013. View Article : Google Scholar
|
|
10
|
Watanabe N, Narita M, Yamahira A,
Taniguchi T, Furukawa T, Yoshida T, Miyazawa T, Nashimoto M and
Takahashi M: Induction of apoptosis of leukemic cells by TRUE gene
silencing using small guide RNAs targeting the WT1 mRNA. Leuk Res.
37:580–585. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stein CA, Hansen JB, Lai J, Wu S,
Voskresenskiy A, Høg A, Worm J, Hedtjärn M, Souleimanian N, Miller
P, et al: Efficient gene silencing by delivery of locked nucleic
acid antisense oligonucleotides, unassisted by transfection
reagents. Nucleic Acids Res. 38:e32010. View Article : Google Scholar :
|
|
12
|
Soifer HS, Souleimanian N, Wu S,
Voskresenskiy AM, Collak FK, Cinar B and Stein CA: Direct
regulation of androgen receptor activity by potent CYP17 inhibitors
in prostate cancer cells. J Biol Chem. 287:3777–3787. 2012.
View Article : Google Scholar :
|
|
13
|
Souleimanian N, Deleavey GF, Soifer H,
Wang S, Tiemann K, Damha MJ and Stein CA: Antisense 2′-deoxy,
2′-fluroarabino nucleic acids (2′F-ANAs) oligonucleotides: In vitro
gymnotic silencers of gene expression whose potency is enhanced by
fatty acids. Mol Ther Nucleic Acids. 1:e432012. View Article : Google Scholar
|
|
14
|
Koller E, Vincent TM, Chappell A, De S,
Manoharan M and Bennett CF: Mechanisms of single-stranded
phosphorothioate modified antisense oligonucleotide accumulation in
hepatocytes. Nucleic Acids Res. 39:4795–4807. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sato MM, Nakashima A, Nashimoto M, Yawaka
Y and Tamura M: Bone morphogenetic protein-2 enhances
Wnt/beta-catenin signaling-induced osteoprotegerin expression.
Genes Cells. 14:141–153. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Uyama M, Sato MM, Kawanami M and Tamura M:
Regulation of osteoblastic differentiation by the proteasome
inhibitor bortezomib. Genes Cells. 17:548–558. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dutta D and Donaldson JG: Search for
inhibitors of endocytosis: Intended specificity and unintended
consequences. Cell Logist. 2:203–208. 2012. View Article : Google Scholar
|
|
18
|
Donaldson JG, Finazzi D and Klausner RD:
Brefeldin A inhibits Golgi membrane-catalysed exchange of guanine
nucleotide onto ARF protein. Nature. 360:350–352. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kastelein JJ, Wedel MK, Baker BF, Su J,
Bradley JD, Yu RZ, Chuang E, Graham MJ and Crooke RM: Potent
reduction of apolipoprotein B and low-density lipoprotein
cholesterol by short-term administration of an antisense inhibitor
of apolipo-protein B. Circulation. 114:1729–1735. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sazani P, Gemignani F, Kang SH, Maier MA,
Manoharan M, Persmark M, Bortner D and Kole R: Systemically
delivered antisense oligomers upregulate gene expression in mouse
tissues. Nat Biotechnol. 20:1228–1233. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vickers TA, Zhang H, Graham MJ, Lemonidis
KM, Zhao C and Dean NM: Modification of MyD88 mRNA splicing and
inhibition of IL-1beta signaling in cell culture and in mice with a
2′-O-methoxyethyl-modified oligonucleotide. J Immunol.
176:3652–3661. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Doherty GJ and McMahon HT: Mechanisms of
endocytosis. Annu Rev Biochem. 78:857–902. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tonkinson JL and Stein CA: Patterns of
intracellular compartmentalization, trafficking and acidification
of 5′-fluorescein labeled phosphodiester and phosphorothioate
oligodeoxynucleotides in HL60 cells. Nucleic Acids Res.
22:4268–4275. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bennett CF and Swayze EE: RNA targeting
therapeutics: Molecular mechanisms of antisense oligonucleotides as
a therapeutic platform. Annu Rev Pharmacol Toxicol. 50:259–293.
2010. View Article : Google Scholar : PubMed/NCBI
|
